US EditioniOncologi, Inc. Announces the Appointment of Dr. Mona Flores and Mr. Paolo Fundarò to Its Board of Directors
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
iOncologi, Inc. Announces the Appointment of Dr. Mona Flores and Mr. Paolo Fundaro to Its Board of Directors
Newswise — GAINESVILLE, Fla., March 17, 2025 /PRNewswire/ -- iOncologi, Inc. (https://bit.ly/42art8n), a clinical-stage biopharmaceutical company pioneering novel immunotherapies for cancer treatment, today announced the appointment of Dr. Mona Flores and Mr. Paolo Fundarò to its Board of Directors. Their combined expertise in AI-driven healthcare innovation, biopharmaceutical leadership, and strategic biotech investment will strengthen iOncolog…
iOncologi, Inc. Announces the Appointment of Dr. Mona Flores and Mr. Paolo Fundarò to Its Board of Directors
GAINESVILLE, Fla., March 17, 2025 /PRNewswire/ — iOncologi, Inc. (www.ioncologi.com), a clinical-stage biopharmaceutical company pioneering novel immunotherapies for cancer treatment, today announced the appointment of Dr. Mona Flores and Mr. Paolo Fundarò to its Board of Directors. Their combined expertise in AI-driven healthcare innovation, biopharmaceutical leadership, and strategic biotech investment will strengthen iOncologi’s mission to ra…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
